Popular stocks with increasing unusual: LLY FCX KO EBAY SNAP CVS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
CVS Health (CVS) PT Lowered to $68 at Baird
February 21, 2019 8:35 AM ESTBaird analyst Eric Coldwell lowered the price target on CVS Health (NYSE: CVS) to $68.00 (from $86.00) while maintaining a Neutral rating. Mid-$7 EPS in 2020 looks like a best-case scenario. Derivative reads scattered throughout CVS update, most of them unfavorable for peers/vendors.
CVS is... More
